nassar, A., anwar, M., Samir, A., youssef, A. (2021). Prognostic Factors in Advanced Laryngeal Cancer: An Egyptian experience. Egyptian Journal of Ear, Nose, Throat and Allied Sciences, 22(22), 1-9. doi: 10.21608/ejentas.2021.57134.1304
ahmed nassar; mohamed anwar; Amr Samir; ahmed youssef. "Prognostic Factors in Advanced Laryngeal Cancer: An Egyptian experience". Egyptian Journal of Ear, Nose, Throat and Allied Sciences, 22, 22, 2021, 1-9. doi: 10.21608/ejentas.2021.57134.1304
nassar, A., anwar, M., Samir, A., youssef, A. (2021). 'Prognostic Factors in Advanced Laryngeal Cancer: An Egyptian experience', Egyptian Journal of Ear, Nose, Throat and Allied Sciences, 22(22), pp. 1-9. doi: 10.21608/ejentas.2021.57134.1304
nassar, A., anwar, M., Samir, A., youssef, A. Prognostic Factors in Advanced Laryngeal Cancer: An Egyptian experience. Egyptian Journal of Ear, Nose, Throat and Allied Sciences, 2021; 22(22): 1-9. doi: 10.21608/ejentas.2021.57134.1304
Prognostic Factors in Advanced Laryngeal Cancer: An Egyptian experience
1Assistant Professor of Otolaryngology department, Cairo University
2Professor of Otolaryngology department, Cairo University
3Assistant Lecturer of Otolaryngology department, Cairo University
4Lecturer of Otolaryngology department, Cairo University
Abstract
Background: In recent years, the survival rate of laryngeal carcinoma patients has been demonstrating a decreasing trend from (57.1% to 51.9%) we retrospectively analyze the various prognostic factors in patients with advanced laryngeal cancer. To explore the best options across the continuum of care for patients. Patients and Methods: A retrospective analytic study evaluating prognostic factors in 110 patients with advanced laryngeal carcinoma. Selected prognostic factors includes age, gender, smoking, tumor subsite, TNM classification, clinical staging, thyroid cartilage invasion, treatment modality, surgical margins, Preoperative tracheostomy, postoperative fistula, associated comorbidities (chronic diseases). Results: All patients were followed up for at least 36 months, the survival rates 1, 2 and 3 years after the treatment were 91.8%, 81% and 68.1% respectively. The disease-free progression rates were 89%, 81% and 71.8% respectively. Conclusion: The increase in Age, Trans-glottic tumors, Thyroid cartilage invasion and Stage-IV AJCC; had an independent effect on increasing the probability of mortality occurrence